BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19480690)

  • 1. Automated detection of residual cells after sex-mismatched stem-cell transplantation - evidence for presence of disease-marker negative residual cells.
    Erlecke J; Hartmann I; Hoffmann M; Kroll T; Starke H; Heller A; Gloria A; Sayer HG; Johannes T; Claussen U; Liehr T; Loncarevic IF
    Mol Cytogenet; 2009 May; 2():12. PubMed ID: 19480690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FISH analysis of native smears from bone marrow and blood for the monitoring of chimerism and clonal markers after stem cell transplantation in children.
    Fuehrer M; Gerusel-Bleck M; Konstantopoulos N; Bender-Goetze C; Walther JU
    Int J Mol Med; 2005 Feb; 15(2):291-7. PubMed ID: 15647846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monitoring of bcr/abl fusion gene by interphase-dual-color and dual-fusion fluorescence in situ hybridization in CML after allo-HSCT].
    Qian SX; Li JY; Zhang R; Hong M; Qiu HR; Li L; Xu W; Sheng RL; Wu HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):577-81. PubMed ID: 16800946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical significance of interphase fluorescence in situ hybridization monitoring chimeric status after sex-mismatched allogeneic hematopoietic stem cell transplantation for leukemia].
    Liu Q; Song L; Zhang Y; Wei Y; Xu D; Sun J; Liu X; Xu B; Meng F; Zhou S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):212-5. PubMed ID: 15793790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.
    Cotteret S; Belloc F; Boiron JM; Bilhou-Nabera C; Dumain P; Boyer C; Lacombe F; Reiffers J; Bernard P
    Cytometry; 1998 Oct; 34(5):216-22. PubMed ID: 9822307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
    Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
    Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed chimerism of bone marrow vessels (endothelial cells, myofibroblasts) following allogeneic transplantation for chronic myelogenous leukemia.
    Kvasnicka HM; Wickenhauser C; Thiele J; Varus E; Hamm K; Beelen DW; Schaefer UW
    Leuk Lymphoma; 2003 Feb; 44(2):321-8. PubMed ID: 12688352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of relapse and evaluation of treatment for mixed chimerism using fluorescence in situ hybridization following allogeneic hematopoietic cell transplant for hematological malignancies.
    Tamura S; Saheki K; Takatsuka H; Wada H; Fujimori Y; Okamoto T; Takemoto Y; Hashimoto-Tamaoki T; Furuyama J; Kakishita E
    Ann Hematol; 2000 Nov; 79(11):622-6. PubMed ID: 11131921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
    Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
    Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse.
    Serrano J; Roman J; Sanchez J; Jimenez A; Castillejo JA; Herrera C; Gonzalez MG; Reina L; Rodriguez MC; Alvarez MA; Maldonado J; Torres A
    Blood; 2000 Apr; 95(8):2659-65. PubMed ID: 10753848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FISH detection of mixed chimerism in 33 patients submitted to bone marrow transplantation.
    Palka G; Stuppia L; Di Bartolomeo P; Morizio E; Peila R; Franchi PG; Calabrese G
    Bone Marrow Transplant; 1996 Feb; 17(2):231-6. PubMed ID: 8640172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined immunophenotyping and FISH with sex chromosome-specific DNA probes for the detection of chimerism in epidermal Langerhans cells after sex-mismatched bone marrow transplantation.
    Hessel H; Mittermüller J; Zitzelsberger H; Weier HU; Bauchinger M
    Histochem Cell Biol; 1996 Nov; 106(5):481-5. PubMed ID: 8950606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of mixed chimerism and leukemic relapse after allogeneic bone marrow transplantation in subpopulations of leucocytes by fluorescent in situ hybridization in combination with the simultaneous immunophenotypic analysis of interphase cells.
    Kögler G; Wolf HH; Heyll A; Arkesteijn G; Wernet P
    Bone Marrow Transplant; 1995 Jan; 15(1):41-8. PubMed ID: 7742754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings.
    Akel S; Kolialexi A; Mavrou A; Metaxotou C; Loukopoulos D; Yataganas X
    Clin Lab Haematol; 2002 Dec; 24(6):361-7. PubMed ID: 12452817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic chimerism in sex-mismatched liver transplant recipients detected by fluorescence in situ hybridization.
    Nagler A; Ilan Y; Amiel A; Eid A; Tur-Kaspa R
    Transplantation; 1994 May; 57(10):1458-61. PubMed ID: 8197608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms.
    Suttorp M; Schmitz N; Dreger P; Schaub J; Löffler H
    Leukemia; 1993 May; 7(5):679-87. PubMed ID: 8097800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of minimal residual disease using fluorescence DNA in situ hybridization: a follow-up study in leukemia and lymphoma patients.
    Nylund SJ; Ruutu T; Saarinen U; Larramendy ML; Knuutila S
    Leukemia; 1994 Apr; 8(4):587-94. PubMed ID: 8152255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional cytogenetics and FISH evaluation of chimerism after sex-mismatched bone marrow transplantation (BMT) and donor leukocyte infusion (DLI).
    Díez-Martín JL; Llamas P; Gosálvez J; López-Fernández C; Polo N; de la Fuente MS; Buño I
    Haematologica; 1998 May; 83(5):408-15. PubMed ID: 9658724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of fluorescence in situ hybridization for detecting the bcr/abl gene fusion in interphase cells of routine bone marrow specimens.
    Werner M; Ewig M; Nasarek A; Wilkens L; von Wasielewski R; Tchinda J; Nolte M
    Diagn Mol Pathol; 1997 Oct; 6(5):282-7. PubMed ID: 9458387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.